Latest Breaking News On - Addex therapeutic - Page 1 : comparemela.com

Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024

Geneva, Switzerland, May 31, 2024 - Addex Therapeutics , a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological.

United statesMikhail kalinichevTim dyerMike sinclairSwiss exchangeJanssen pharmaceuticals incTranslational scienceAddex therapeuticsConference callParticipant dial inAmerican depositary sharesForward looking statementsPrivate securities litigation reform actAddex therapeutic annual reportAddex therapeutic

Addex to Present at Bio€quity Europe 2024

Addex to Present at Bio€quity Europe 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesTim dyerMike sinclairSwiss exchangeJanssen pharmaceuticals incKursaal congress centerSan sebastiMonday mayAmerican depositary sharesForward looking statementsPrivate securities litigation reform actAddex therapeutic annual reportAddex therapeuticsAddex therapeutic

Addex Provides Update on ADX71149 Phase 2 Epilepsy Study

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 29, 2024 - Addex Therapeutics , a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small.

United statesTim dyerRoger millsMike sinclairSwiss exchangeJanssen pharmaceuticals incChief medical officerJanssen pharmaceuticalsAmerican depositary sharesForward looking statementsPrivate securities litigation reform actAddex therapeutic annual reportAddex therapeuticsAddex therapeutic

Addex s Janssen-partnered epilepsy drug fails phase 2 trial

Addex s Janssen-partnered epilepsy drug fails phase 2 trial
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Tim dyerRoger millsAddex therapeuticFierce biotechMedical officer roger millsNasdaq capital marketPerceptive advisors

Addex to Present at the Swiss Biotech Day 2024

Geneva, Switzerland, April 19, 2024 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug development, announced today that CEO, Tim Dyer, will.

United statesMike sinclairTim dyerJanssen pharmaceuticals incCongress centerSwiss exchangeSwiss biotech dayAddex therapeuticsJanssen pharmaceuticalsAmerican depositary sharesExecutive officerHalsin partnersForward looking statementsPrivate securities litigation reform actAddex therapeutic annual reportAddex therapeutic